ArticleBlood advances2025

Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis.

Samira Glaeser-Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.